Natco Pharma submits copy of press release

25 Aug 2016 Evaluate

Natco Pharma has submitted a copy of Press Release dated August 25, 2016 titled ‘NATCOs marketing partner Mylan Invalidates Two of Tevas Copaxone 40 mg/mL Patents Via US Patent and Trademark Offices Inter Partes Review Proceeding’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1024.00 -15.45 (-1.49%)
11-Mar-2026 13:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.60
Dr. Reddys Lab 1326.30
Cipla 1335.00
Zydus Lifesciences 927.95
Lupin 2364.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×